ACI-24.060

· AC Immune SA

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ACI-24.060, covering 2025-12-15 to 2025-12-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study) [Phase 1, Phase 2]

See pricing